Meanwhile, restoring SUMO1 expression through gene manipulation (e.g., heart-specific SUMO1-transgenic mice) or gene therapy (e.g., AAV9 vector encoding SUMO1) in mice with HF improved cardiac performance and enhanced the survival rate (114). This evidence concerns the gene SUMO1 and hydrops fetalis.